Gurbel PA - Search Results

1

Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registry.

Baber U, Mehran R, Kirtane AJ, Gurbel PA, Christodoulidis G, Maehara A, Witzenbichler B, Weisz G, Rinaldi MJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri EL Jr, Xu K, Parise H, Brodie BR, Stuckey TD, Stone GW. Baber U, et al. Among authors: gurbel pa. Circ Cardiovasc Interv. 2015 Jun;8(6):e001683. doi: 10.1161/CIRCINTERVENTIONS.115.001683. Circ Cardiovasc Interv. 2015. PMID: 26056248

2

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity.

Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM. Gurbel PA, et al. Circulation. 2003 Jun 17;107(23):2908-13. doi: 10.1161/01.CIR.0000072771.11429.83. Epub 2003 Jun 9. Circulation. 2003. PMID: 12796140 Clinical Trial.

3

Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial.

Hermiller JB, Raizner A, Cannon L, Gurbel PA, Kutcher MA, Wong SC, Russell ME, Ellis SG, Mehran R, Stone GW; TAXUS-IV Investigators. Hermiller JB, et al. Among authors: gurbel pa. J Am Coll Cardiol. 2005 Apr 19;45(8):1172-9. doi: 10.1016/j.jacc.2004.10.075. J Am Coll Cardiol. 2005. PMID: 15837245 Free article. Clinical Trial.

4

The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor.

Gurbel PA. Gurbel PA. Rev Cardiovasc Med. 2006;7 Suppl 4:S20-8. Rev Cardiovasc Med. 2006. PMID: 17224887 Review.

5

Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?

Bliden KP, DiChiara J, Tantry US, Bassi AK, Chaganti SK, Gurbel PA. Bliden KP, et al. Among authors: gurbel pa. J Am Coll Cardiol. 2007 Feb 13;49(6):657-66. doi: 10.1016/j.jacc.2006.10.050. Epub 2007 Jan 26. J Am Coll Cardiol. 2007. PMID: 17291930 Free article.

6

Stent thrombosis: role of compliance and nonresponsiveness to antiplatelet therapy.

Gurbel PA, Tantry US. Gurbel PA, et al. Rev Cardiovasc Med. 2007;8 Suppl 1:S19-26. Rev Cardiovasc Med. 2007. PMID: 17401307 Review.

7

Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.

Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, Gesheff T, Chaganti SK, Etherington A, Tantry US. Gurbel PA, et al. Circulation. 2007 Jun 26;115(25):3156-64. doi: 10.1161/CIRCULATIONAHA.106.675587. Epub 2007 Jun 11. Circulation. 2007. PMID: 17562955 Clinical Trial.

8

Antiplatelet therapy after implantation of drug-eluting stents: duration, resistance, alternatives, and management of surgical patients.

Gurbel PA, DiChiara J, Tantry US. Gurbel PA, et al. Am J Cardiol. 2007 Oct 22;100(8B):18M-25M. doi: 10.1016/j.amjcard.2007.08.018. Am J Cardiol. 2007. PMID: 17950828 Review.

9

Platelet function monitoring in patients with coronary artery disease.

Gurbel PA, Becker RC, Mann KG, Steinhubl SR, Michelson AD. Gurbel PA, et al. J Am Coll Cardiol. 2007 Nov 6;50(19):1822-34. doi: 10.1016/j.jacc.2007.07.051. Epub 2007 Oct 23. J Am Coll Cardiol. 2007. PMID: 17980247 Free article. Review.

10

Peri-procedural platelet function and platelet inhibition in percutaneous coronary intervention.

Kereiakes DJ, Gurbel PA. Kereiakes DJ, et al. Among authors: gurbel pa. JACC Cardiovasc Interv. 2008 Apr;1(2):111-21. doi: 10.1016/j.jcin.2008.01.005. JACC Cardiovasc Interv. 2008. PMID: 19463287 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

511 results

Search Page

Filters